SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bosco who wrote (967)6/20/2000 5:03:00 PM
From: david james   of 1298
 
Cell Genesys also got a patent today. Looks like this one just came through this afternoon, so even the company may just be learning about it.

6,077,947
Capon et al. June 20, 2000
Assignee: Cell Genesys, Inc. (Foster City, CA)
DNA encoding an intracellular chimeric receptor comprising Janus kinase

Abstract

The present invention is directed to novel chimeric proliferation receptor proteins and DNA sequences encoding these proteins where the chimeric proteins
are characterized in three general categories. In one category, the novel chimeric proteins comprise at least three domains, namely, an extracellular
inducer-responsive clustering domain capable of binding an extracellular inducer that transmits a signal to a proliferation signaling domain, a
transmembrane domain and a proliferation signaling domain that signals a host cell to divide. In the second category, the novel chimeric proteins comprise
at least two domains, namely, an intracellular inducer-responsive clustering domain capable of binding an intracellular inducer and a proliferation signaling
domain that signals the cell to divide. In yet a third category, a novel hybrid chimeric protein receptor is contemplated that contains an intracellular or
extracellular inducer domain, a transmembrane domain, a proliferation signaling domain and an effector signaling domain in a single chain molecule.
Whether the binding domain is intracellular or extracellular, the binding of inducer to these novel chimeric receptor proteins induces the clustering of the
binding domains to each other and further signals the cell to proliferate, and optionally, signal an effector function. The present invention further relates to
expression vectors containing the nucleic acids encoding the novel chimeric receptors, cells expressing the novel chimeric receptors and therapeutic
methods of using cells expressing these novel receptors for the treatment of cancer, infectious disease and autoimmune diseases, for example.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext